Lynas (ASX:LYC) share price on watch following Malaysia update

Lynas Malaysia is copping a few hits, it announced this morning.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Lynas Rare Earths Ltd (ASX: LYC) share price could be a mover on Monday after the company provided an update on its Malaysian operations.

The Lynas Malaysia plant treats concentrate from Mt Weld in Western Australia. It also produces separated rare earth oxide products for sale to customers across Asia, Europe and North America.

A woman stares at a computer with her face just inches from the screen.

Image source: Getty Images

What might move the Lynas share price on Monday?

Malaysia COVID-19 update

Lynas advised that its Malaysia plant continues to operate at a reduced rate. This is in line with its commitment to the health and safety of its employees. It is also to comply with local government standard operating procedures.

The company highlighted the vaccination of team members as an important step in protecting the health and safety of local workers. Participation in vaccination is part of the Malaysian Government's recovery plan, on the path to relaxing certain lockdown policies.

Lynas advised that 98% of its staff in Malaysia have received their first vaccination dose. And 94% have received their second dose.

Today's announcement provided no specific production guidance.

Lynas' update for the quarter ending in June flagged that staff numbers on site were limited to 40% of the total workforce. Despite various COVID-19 and resource-related challenges, Lynas Malaysia was operating at approximately 75% of production rates.

New Malaysia facility approvals

Another potential catalyst for the Lynas share price is its update related to construction commencing on the Permanent Disposal Facility. This facility treats low-level radioactive waste in Malaysia.

Lynas advised that local regulators have extended the deadline for the satisfaction of the licence condition by 6 months to 2 March 2022. The company said that it continues to engage productively with the relevant government and regulatory authorities to progress approvals for the facility.

Anti-Lynas activists appeal

The prospect of radioactive waste has concerned many locals. This is following the government's decision to renew the company's rare earth plant licence.

On 28 July, the High Court of Malaya dismissed the judicial review proceedings commenced by the anti-Lynas activists. The activists are seeking a review of processes after the Government of Malaysia renewed Lynas Malaysia's fourth operating licence in August 2019.

According to today's announcement, Lynas received a notice of appeal by anti-Lynas activists.

Lynas said that it intends to defend the appeal.

Lynas share price snapshot

The Lynas share price has tumbled 18% in a week to a close of $6.33 on Friday.

Still, Lynas shares are up a pleasing 59% year to date and 155% over the last 12 months.

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A panel of four judges hold up cards all showing the perfect score of ten out of ten
Share Gainers

Here are the top 10 ASX 200 shares today

It was a veritable party on the ASX today.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

ASX board.
Share Market News

ASX 200 charges higher again as relief rally gathers pace

The ASX 200 keeps climbing as global tensions begin to ease.

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Dateline, Karoon Energy, Lindian, and PEXA shares are falling today

These shares are missing out on the good times on Wednesday. But why?

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why Arafura Rare Earths, Eagers Automotive, Life360, and Pro Medicus shares are racing higher today

These shares are having a good session on hump day. But why?

Read more »

A man slumps crankily over his morning coffee as it pours with rain outside.
Share Fallers

These were the worst-performing ASX 200 shares in March

These shares were out of form in March. Let's see why investors sold them off.

Read more »